Guide

Can you get retatrutide in Australia?

Not as a medicine. Still in Phase 3 trials and unregistered by the TGA or any other regulator, retatrutide is something Chemist Warehouse cannot stock and compounding pharmacies cannot supply. The only form available locally is research-grade: Peptide Aus ships lyophilised vials from 10mg to 60mg and retatrutide pens from 15mg to 70mg out of Australian stock, for laboratory use.

Peptide Aus · Updated 5 September 2026 · For in-vitro research; not medical or dosing advice.

How far along retatrutide's development is

Retatrutide (LY3437943) is Eli Lilly's triple agonist at the GLP-1, GIP and glucagon receptors. Its Phase 2 data appeared in the New England Journal of Medicine in 2023, and that same year the Phase 3 program, TRIUMPH, opened across obesity, type 2 diabetes, sleep apnoea and knee osteoarthritis. Those Phase 3 results should land through 2026, and only then could Lilly submit to regulators one jurisdiction at a time.

No marketing, prescribing or dispensing of retatrutide as a medicine is possible in Australia before the TGA has evaluated and registered it. Because that review usually runs a year or more after a submission, any realistic pharmacy availability sits well beyond the end of the trials.

Pharmacies: Chemist Warehouse, Priceline and the rest

High-street pharmacies carry registered medicines only. Retatrutide is not registered, so no Australian pharmacy carries it and a hunt for a retatrutide price at Chemist Warehouse comes up empty. Where a pharmacy site seems to show it, read the product name closely: the listing is almost always tirzepatide (Mounjaro) or semaglutide (Ozempic, Wegovy), both registered and available only on prescription.

Retatrutide pens

Trial participants receive retatrutide by weekly injection using a study-specific device, and no pharmaceutical pen has been registered in any country. As research devices, Peptide Aus offers its own retatrutide pens in 15mg, 20mg, 30mg and 70mg: a pre-filled 3 mL aqueous dial-a-dose unit with 0.5 mg clicks, nothing to mix, dispatched cold from Australian stock, and a batch certificate on request. The retatrutide pen page sets out the four strengths and when a pen fits a research design better than a vial does.

Compounding pharmacies

A compounding pharmacy in Australia may prepare medicines from approved raw materials for a named patient holding a prescription. Compounding an unapproved investigational drug for supply is not lawful, and in 2024 the TGA tightened the compounding rules covering GLP-1-class products. Treat any compounding pharmacy that offers retatrutide with the same wariness you would an online pen.

Clinical trials in Australia

Australian hospitals and research centres are among the TRIUMPH sites. Enrolment runs through each site's recruiting clinician, and the protocol sets who is eligible. Open sites are listed on the Australian New Zealand Clinical Trials Registry and on clinicaltrials.gov, which is where a search for 'retatrutide trial sign up Australia' should take you, rather than to a supplier.

What research-grade retatrutide actually is

From Peptide Aus, retatrutide comes as lyophilised powder in 10mg, 15mg, 20mg, 30mg and 60mg vials, and as retatrutide pens in 15mg, 20mg, 30mg and 70mg, each with a batch certificate of analysis on request. Every format is a research reagent for in-vitro laboratory study. None is a medicine, a treatment, or cleared for human or veterinary use.

The legal picture is simple: research reagents may be sold for laboratory use, and lawful use is the buyer's responsibility. Supplying any of it for human use would need a registration that does not exist.

Frequently asked questions

When can Australians expect retatrutide?

There is no date. The Phase 3 trials continue through 2026, and TGA registration would only come after a submission beyond that point. Any claim of earlier 'availability' is pointing at research material, not a medicine.

Do you stock a retatrutide pen?

We do. Retatrutide pens come in 15mg, 20mg, 30mg and 70mg, with other strengths made to order, supplied as research devices from Australian stock next to the vials. They are neither a pharmacy product nor approved for human use.

Is retatrutide legal in Australia?

Research-grade retatrutide may be sold and bought for laboratory use. It carries no human-use approval, cannot be prescribed, and the buyer is responsible for lawful use.

Could my doctor write me a script for retatrutide?

No. A prescriber can only prescribe registered medicines, or apply through the TGA's Special Access Scheme for an unapproved product; that scheme is meant for serious conditions with no alternative and is not used for investigational obesity drugs.